Clinical Trial Update: Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 clinical trial evaluating treatment for high-risk newly diagnosed multiple myeloma with minimal residual disease d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Newly Diagnosed, High Risk | Phase 4 | Status: RECRUITING